Amundi Asset Management US’s Teva Pharmaceuticals TEVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2021
Q1
$2.6M Buy
225,185
+2,009
+0.9% +$23.2K ﹤0.01% 1146
2020
Q4
$2.16M Buy
223,176
+16,309
+8% +$157K ﹤0.01% 1121
2020
Q3
$1.86M Buy
206,867
+59,928
+41% +$540K ﹤0.01% 1099
2020
Q2
$1.81M Buy
146,939
+37,726
+35% +$465K ﹤0.01% 1085
2020
Q1
$981K Sell
109,213
-18,126
-14% -$163K ﹤0.01% 1094
2019
Q4
$1.25M Buy
127,339
+26,028
+26% +$255K ﹤0.01% 1195
2019
Q3
$697K Sell
101,311
-4,400
-4% -$30.3K ﹤0.01% 1265
2019
Q2
$976K Buy
105,711
+3,950
+4% +$36.5K ﹤0.01% 1236
2019
Q1
$1.6M Buy
101,761
+9,571
+10% +$150K ﹤0.01% 1115
2018
Q4
$1.42K Buy
92,190
+18,324
+25% +$282 ﹤0.01% 1086
2018
Q3
$1.59M Buy
73,866
+1,369
+2% +$29.5K ﹤0.01% 1150
2018
Q2
$1.76M Buy
72,497
+1,297
+2% +$31.6K ﹤0.01% 1147
2018
Q1
$1.22M Buy
71,200
+12,158
+21% +$208K ﹤0.01% 1157
2017
Q4
$1.12M Buy
+59,042
New +$1.12M ﹤0.01% 1187
2016
Q1
Sell
-354,962
Closed -$23.3M 578
2015
Q4
$23.3M Sell
354,962
-1,284,267
-78% -$84.3M 0.09% 196
2015
Q3
$92.6M Buy
1,639,229
+483,763
+42% +$27.3M 0.38% 75
2015
Q2
$68.3M Buy
1,155,466
+7,888
+0.7% +$466K 0.25% 113
2015
Q1
$71.5M Buy
1,147,578
+111,857
+11% +$6.97M 0.26% 106
2014
Q4
$59.6M Buy
1,035,721
+797,760
+335% +$45.9M 0.22% 125
2014
Q3
$12.8M Buy
237,961
+10,196
+4% +$548K 0.05% 307
2014
Q2
$11.9M Buy
227,765
+209,947
+1,178% +$11M 0.05% 315
2014
Q1
$942K Sell
17,818
-60,600
-77% -$3.2M ﹤0.01% 581
2013
Q4
$3.14M Sell
78,418
-772,960
-91% -$31M 0.01% 501
2013
Q3
$32.2M Buy
851,378
+88,907
+12% +$3.36M 0.13% 186
2013
Q2
$29.9M Buy
+762,471
New +$29.9M 0.12% 200